Literature DB >> 18456450

Chlamydia pneumoniae infection in IL-10 knock out mice: accelerated clearance but severe pulmonary inflammatory response.

Tuula Penttilä1, Anu Haveri, Anne Tammiruusu, Jenni M Vuola, Riitta Lahesmaa, Mirja Puolakkainen.   

Abstract

In interleukin-10 knock out (IL-10 KO) mice, accelerated clearance of pulmonary Chlamydia pneumoniae infection was observed. On the other hand, the histopathological changes in lung tissue were more pronounced in IL-10 KO mice at all time points after infection and repeated infection than in the wild type mice. Both ex vivo induced antigen-specific proliferation as well as production of proinflammatory cytokines by splenocytes were higher in IL-10 KO mice than in WT mice. Also, intrapulmonary proinflammatory cytokine levels were higher in IL-10 KO mice than in the WT mice. The lack of anti-inflammatory action of IL-10 is likely to contribute to the enhanced clearance but severe inflammation in this experimental model.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18456450     DOI: 10.1016/j.micpath.2008.02.004

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  11 in total

Review 1.  Significant roles played by IL-10 in Chlamydia infections.

Authors:  Hamid Hakimi; Mohammad Zare-Bidaki; Nahid Zainodini; Shokrollah Assar; Mohammad Kazemi Arababadi
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

Review 2.  Interleukin-10 and immunity against prokaryotic and eukaryotic intracellular pathogens.

Authors:  Joshua C Cyktor; Joanne Turner
Journal:  Infect Immun       Date:  2011-05-16       Impact factor: 3.441

3.  Host cell cytokines induced by Chlamydia pneumoniae decrease the expression of interstitial collagens and fibronectin in fibroblasts.

Authors:  Jürgen Baumert; Karl-Hermann Schmidt; Annett Eitner; Eberhard Straube; Jürgen Rödel
Journal:  Infect Immun       Date:  2008-12-01       Impact factor: 3.441

Review 4.  Immunopathogenesis of Chlamydial Infections.

Authors:  Ashlesh K Murthy; Weidang Li; Kyle H Ramsey
Journal:  Curr Top Microbiol Immunol       Date:  2018       Impact factor: 4.291

5.  Heat-shock response increases lung injury caused by Pseudomonas aeruginosa via an interleukin-10-dependent mechanism in mice.

Authors:  Michel Carles; Brant M Wagener; Mathieu Lafargue; Jérémie Roux; Karen Iles; Dong Liu; Cilina Ann Rodriguez; Naseem Anjum; Jaroslaw Zmijewski; Jean-Ehrland Ricci; Jean-Francois Pittet
Journal:  Anesthesiology       Date:  2014-06       Impact factor: 7.892

6.  The anti-inflammatory cytokine, interleukin-10, inhibits inflammatory mediators in human epithelial cells and mouse macrophages exposed to live and UV-inactivated Chlamydia trachomatis.

Authors:  Abebayehu N Yilma; Shree R Singh; Stacie J Fairley; Murtada A Taha; Vida A Dennis
Journal:  Mediators Inflamm       Date:  2012-02-19       Impact factor: 4.711

7.  Plasmacytoid dendritic cells mediate the regulation of inflammatory type T cell response for optimal immunity against respiratory Chlamydia pneumoniae infection.

Authors:  Antony George Joyee; Xi Yang
Journal:  PLoS One       Date:  2013-12-26       Impact factor: 3.240

8.  Suppressors of Cytokine Signaling (SOCS)1 and SOCS3 Proteins Are Mediators of Interleukin-10 Modulation of Inflammatory Responses Induced by Chlamydia muridarum and Its Major Outer Membrane Protein (MOMP) in Mouse J774 Macrophages.

Authors:  Skyla A Duncan; Rajnish Sahu; Saurabh Dixit; Shree R Singh; Vida A Dennis
Journal:  Mediators Inflamm       Date:  2020-06-24       Impact factor: 4.711

Review 9.  Insights Into Host Cell Cytokines in Chlamydia Infection.

Authors:  Wenjing Xiang; Nanyan Yu; Aihua Lei; Xiaofang Li; Shui Tan; Lijun Huang; Zhou Zhou
Journal:  Front Immunol       Date:  2021-05-21       Impact factor: 7.561

10.  STAT3 modulates cigarette smoke-induced inflammation and protease expression.

Authors:  Patrick Geraghty; Anne E Wyman; Itsaso Garcia-Arcos; Abdoulaye J Dabo; Sonya Gadhvi; Robert Foronjy
Journal:  Front Physiol       Date:  2013-10-01       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.